LAST UPDATED: Jan 31, 2025
https://www.pcds.org.uk/patient-info-leaflets/subacute-cutaneous-lupus-erythematosus
Cutaneous lupus erythematosus (LE) is a diverse group of autoimmune connective tissue disorders localised to the skin that can be associated with systemic lupus erythematosus (involving other organs within the body) to varying degree.
Subacute cutaneous lupus erythematosus (SCLE) is type of cutaneous lupus erythematosus characterised by scaly, raised and/or ring-shaped skin changes usually affecting areas of sun-exposed skin such as the ‘V’ of the neckline, scalp, arms, and upper back; the face is often unaffected.
SCLE is an autoimmune disease, in which the body’s natural defence system can’t tell the difference between your own cells and foreign cells, causing the body to mistakenly attack normal cells.
It is thought that a combination of genetic and environmental factors most likely contribute to the development of SCLE.
Patients can be of any age, sex, or ethnicity. However, SCLE is most common in middle-aged women, except in cases caused by medications, when it often presents in older people.
Genetically, SCLE is associated with the human leukocyte antigen (HLA); there are several other genetic associations. Sometimes lupus erythematosus and related conditions run in families, but this is rare.
Ultraviolet radiation (UVR), from sunlight and sunbeds, is an important trigger for SCLE; an association with smoking has been proposed but is not certain.
Approximately one-third of cases are caused by medications; including some blood pressure and antacid medications such as proton pump inhibitors (PPIs). Drug-induced lupus is more common in older people, and may cause more widespread skin changes. It is important that you should not stop any medication without first discussing it with your doctor. Most cases of drug-induced SCLE are reversible on stopping the offending drug, although resolution can take up to 12 months (most improve within 3 months).
The two most importing things are related to smoking and UV-protection.
If you smoke, we strongly recommend that you stop. In some people smoking can make SCLE worse and may result in a poorer response to treatment.
The most important UV protective measures are:
In the majority of cases you will need to be referred to a specialist, who could be a dermatologist or a GPwER/GPwSI (a GP who has been trained in relevant areas of dermatology).
In most cases it is necessary to take a small sample of skin (a biopsy) to be examined under a microscope in order to confirm the diagnosis. Other tests may be performed including blood and urine tests.
SCLE can have a significant psychological impact and may affect many areas of daily life including work and personal relationships. If you require support with your mental health, then discuss this with a healthcare professional.
If you are affected by SCLE and become pregnant, certain antibodies called anti-Ro/SSA and/or anti-La/SSB from your blood can cross the placenta and, very rarely, affect your baby causing a rash and/or a slow heartbeat. If you are considering pregnancy, please discuss this with the doctor.
If a particular medication has caused the condition, it make take many months after the drug is stopped before the skin improves. In the majority of other cases, there is no cure but there are many treatments that can help.
If you, a family member, or friend have an undiagnosed skin condition; or you want to learn more about how to treat skin conditions, please view our short video on how to get the best from this website.
Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.
Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.
The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes